par Metzger-Filho, Otto;Catteau, A.;Michiels, Stefan 
;Buyse, Marc;Ignatiadis, Michail ;Saini, Kamal ;de Azambuja, Evandro ;Fasolo, Virginie;Naji, Sihem;Canon, Jean Luc;Delree, Paul;Coibion, Michel ;Cusumano, Pino;Jossa, Veronique;Kains, Jean-Pierre;Larsimont, Denis ;Richard, Vincent ;Faverly, Daniel;Cornez, Nathalie ;Vuylsteke, Peter;Vanderschueren, Brigitte;Peyro-Saint-Paul, Hélène;Piccart-Gebhart, Martine ;Sotiriou, Christos
Référence PloS one, 8, 8, page (e66848)
Publication Publié, 2013
;Buyse, Marc;Ignatiadis, Michail ;Saini, Kamal ;de Azambuja, Evandro ;Fasolo, Virginie;Naji, Sihem;Canon, Jean Luc;Delree, Paul;Coibion, Michel ;Cusumano, Pino;Jossa, Veronique;Kains, Jean-Pierre;Larsimont, Denis ;Richard, Vincent ;Faverly, Daniel;Cornez, Nathalie ;Vuylsteke, Peter;Vanderschueren, Brigitte;Peyro-Saint-Paul, Hélène;Piccart-Gebhart, Martine ;Sotiriou, Christos Référence PloS one, 8, 8, page (e66848)
Publication Publié, 2013
Article révisé par les pairs
| Résumé : | Genomic Grade Index (GGI) is a 97-gene signature that improves histologic grade (HG) classification in invasive breast carcinoma. In this prospective study we sought to evaluate the feasibility of performing GGI in routine clinical practice and its impact on treatment recommendations. |
